Stroke Data Public Reporting   

Stroke Data Public Reporting

Hackensack University Medical Center Public Reporting

Hackensack University Medical Center (HUMC) is a state-recognized and Joint Commission Certified Comprehensive Stroke program, the highest designation available. HUMC also achieved the highest recognition for quality and speed, Get With The Guidelines®‒Stroke Gold Plus Achievement Award with Target: Stroke Honor Roll Elite Plus and Target: Type 2 Diabetes Honor Roll. The award recognizes 85 percent or higher adherence to quality indicators for two or more years, and measures to increase the speed of administering clot-busting tPA.

Clinical Outcomes

A Stroke Program achieves comprehensive status for its high volume, quality measures, and progressive stroke therapies that are available 24/7. Our stroke volume and outcomes data are publicly reported according to Comprehensive Stroke Center requirements. This data reflects stroke admissions to Hackensack University Medical Center. 

HACKENSACK UNIVERSITY MEDICAL CENTER VOLUMES

Stroke Types

2022

2023

Ischemic Strokes

620

703

Intracerebral Hemorrhage

109

113

Subarachnoid Hemorrhage

 63

  56

Treatment rates for acute ischemic stroke remain low in the United States. Approximately, 11 percent of all strokes receive treatment utilizing IV Alteplase.

Ischemic Stroke Treatment Rate

2022

2023

National Average

Alteplase (tPA)

16.5%

15%

          11.8%

Mechanical Thrombectomy

14.4%

18.7%

             8%

Stroke Prevention

Often strokes occur as the result of a blockage in one of the carotid arteries (two main arteries in the neck that supply blood to the brain). In order to prevent a stroke caused by a blocked artery, patients may undergo a procedure to remove the blockage, either carotid artery stenting or carotid endarterectomy. HUMC complication rates are superior to the national benchmark.

Surgical Complication Rate

2022

2023

Benchmark

Endovascular Angiograms

0%

0%

1%

Carotid Interventions

1.9%

1.8%

<6%

JFK University Medical Center Public Reporting

JFK University Medical Center is a state-recognized and Joint Commission-certified Comprehensive Stroke program, the highest designation available. JFKUMC also achieved the highest recognition for quality and speed, Get With The Guidelines®‒Stroke Gold Plus Achievement Award with Target: Stroke Honor Roll Elite and Target: Type 2 Diabetes Honor Roll. The award recognizes 85 percent or higher adherence to quality indicators for two or more years, and measures to increase the speed of administering clot-busting thrombolytics. Clinical Outcomes A Stroke Program achieves comprehensive status for its high volume, quality measures, and progressive stroke therapies that are available 24/7. Our stroke volume and outcomes data are publicly reported according to Comprehensive Stroke Center requirements. This data reflects stroke admissions to JFK University Medical Center. 

JFK UNIVERSITY MEDICAL CENTER VOLUMES

Stroke Types

2020 volume

2021 volume

Ischemic Strokes

714

625

Intracerebral Hemorrhage

97

132

Subarachnoid Hemorrhage

24

33

Treatment rates for acute ischemic stroke remain low in the United States. Approximately, 11% percent of all strokes receive treatment utilizing IV Thrombolytics.

Ischemic Stroke Treatment Rate

2020

2021

2021 National Average for Comprehensive Stroke Programs

Intravenous Thrombolytics

11.4%

14.2%

11.9%

Mechanical Thrombectomy

21%

21.4%

11.4%

Post-Treatment Reperfusion 

80.4%

82.9%

85.4%

Stroke Prevention

Often strokes occur as the result of a blockage in one of the carotid arteries (two main arteries in the neck that supply blood to the brain). In order to prevent a stroke caused by a blocked artery, patients may undergo a procedure to remove the blockage, either carotid artery stenting or carotid endarterectomy. JFKUMC complication rates are superior to the national benchmark.

Surgical Complication Rate

2020

2021

Benchmark

Endovascular Angiograms

1.2%

0.5%

1%

Carotid Interventions

2.24 %

0 %

<6%

Jersey Shore University Medical Center Public Reporting

Jersey Shore University Medical Center is a state-recognized and Joint Commission-certified Comprehensive Stroke program, the highest designation available. JSUMC also achieved the highest recognition for quality and speed, Get With The Guidelines®‒ 2022 Gold Plus, Target: Stroke Elite Plus, Target: Stroke Advanced Therapy, Target: Type 2 Diabetesrecognitions The award recognizes 85 percent or higher adherence to quality indicators for two or more years, and measures to increase the speed of administering clot-busting thrombolytics.

Clinical Outcomes

A Stroke Program achieves comprehensive status for its high volume, quality measures, and progressive stroke therapies that are available 24/7. Our stroke volume and outcomes data are publicly reported according to Comprehensive Stroke Center requirements. This data reflects stroke admissions to Jersey Shore University Medical Center. 

JERSEY SHORE UNIVERSITY MEDICAL CENTER VOLUMES

Stroke Types

2020 volume

2021 volume

Ischemic Strokes

542

588

Intracerebral Hemorrhage

134

155

Subarachnoid Hemorrhage

57

59

Treatment rates for acute ischemic stroke remain low in the United States. Approximately, 11% percent of all strokes receive treatment utilizing IV Thrombolytics.

Ischemic Stroke Treatment Rate

2020

2021

2021 National Average for Comprehensive Stroke Programs

Intravenous Thrombolytics

20%

16%

11.9%

Mechanical Thrombectomy

13.4%

18.9%

11.4%

Post-Treatment Reperfusion 

83.2%

84%

85.4%

Stroke Prevention

Often strokes occur as the result of a blockage in one of the carotid arteries (two main arteries in the neck that supply blood to the brain). In order to prevent a stroke caused by a blocked artery, patients may undergo a procedure to remove the blockage, either carotid artery stenting or carotid endarterectomy. JSUMC complication rates are superior to the national benchmark.

Surgical Complication Rate

2020

2021

Benchmark

Endovascular Angiograms

1%

0.8%

1%

Carotid Interventions

0.8%

3.4 %

<6%

We use cookies to improve your experience. Please read our Privacy Policy or click Accept.
X